
Narmada Gelatines Q4 FY26 Results: PAT Rs 10 Cr
Updated: 27 May 2026 • 9:44 am
Posted by:

Narmada Gelatines Q4 FY26 results were declared on May 25, 2026. The company reported PAT of Rs 10 crore for the quarter ended March 31, 2026, up 66.7% YoY compared to Rs 6 crore in Q4 FY25. Revenue from operations was Rs 62 crore, up 24.0% YoY. Results are on a Consolidated basis. Narmada Gelatines is a Gelatine and Ossein company listed on Indian stock exchanges.
Click Here – Get Free Investment Predictions
Narmada Gelatines Q4 FY26 Financial Highlights
| Metric | Q4 FY26 (Rs Cr) | Q4 FY25 (Rs Cr) | YoY Change |
|---|---|---|---|
| Revenue | Rs 62 crore | Rs 50 crore | +24.0% |
| Net Profit | 10 | 6 | +66.7% |
| Basis | Consolidated | ||
Note: Narmada Gelatines Q4 FY26 results declared May 25, 2026. Data sourced from Screener.in BSE filings. Verify from audited statements before investment decisions.
Narmada Gelatines Q4 FY26 Performance Analysis
The Narmada Gelatines Q4 FY26 results reflect the company’s financial performance during the January to March 2026 quarter. The quarter shows strong PAT growth of 66.7% YoY. Narmada Gelatines operates in the Gelatine and Ossein sector, supported by India’s GDP growth above 6.5% and domestic demand conditions in FY26.
Revenue of Rs 62 crore was up 24.0% YoY. Strong revenue growth reflects market expansion and healthy demand.
Screen the best stocks on the Univest Screener.
Key Factors Driving Narmada Gelatines Q4 FY26 Results
Revenue and Business Performance
Revenue of Rs 62 crore in Narmada Gelatines Q4 FY26 was up 24.0% YoY. Double-digit revenue growth reflects strong demand and market share gains. The January to March quarter is the fiscal year-end period characterised by strong execution cycles and year-end activity across Indian companies.
Profitability and Margin Trends
The the business PAT of Rs 10 crore up 66.7% YoY. Strong PAT growth demonstrates improving operational leverage.
India Macro Environment Q4 FY26
India’s macroeconomic environment in Q4 FY26 was supportive with GDP growth above 6.5%, government capex of Rs 11.21 lakh crore budgeted for FY27, and resilient domestic consumption. The Reserve Bank of India’s accommodative stance supported credit conditions. The Gelatine and Ossein sector benefited from these structural tailwinds during the January to March 2026 quarter.
FY27 Outlook
Following the firm results, management guidance on FY27 revenue growth, margin improvement roadmap, and capital allocation priorities will be key investor watchpoints. The Gelatine and Ossein sector continues to benefit from India’s long-term structural growth story. Sustaining the strong profitability momentum will be the FY27 priority.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
Frequently Asked Questions on the company
What is Narmada Gelatines Q4 FY26 net profit?
Ans. Narmada Gelatines Q4 FY26 reported PAT of Rs 10 crore, up 66.7% YoY from Rs 6 crore in Q4 FY25. Results declared May 25, 2026, on a Consolidated basis.
What is Narmada Gelatines Q4 FY26 revenue?
Ans. Narmada Gelatines Q4 FY26 revenue was Rs 62 crore, up 24.0% YoY. Verify from BSE/NSE filings.
When were Narmada Gelatines Q4 FY26 results declared?
Ans. Narmada Gelatines Q4 FY26 results were declared on May 25, 2026, at the board of directors meeting approving audited Q4 and FY26 financial statements.
Is Narmada Gelatines a good investment after Q4 FY26?
Ans. Investment decisions require individual assessment of fundamentals, valuation, and risk tolerance. This article is educational only. Consult a SEBI-registered financial advisor before investing.
Investments in securities are subject to market risk. This content is for educational purposes only. Verify all figures from BSE/NSE filings. Consult a SEBI-registered financial advisor.
Recent Articles
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Polycab India Share Price Today: Should You Buy or Not?
Sun Pharmaceutical Industries Share Price Today: Should You Buy or Not?
Sansera Engineering Share Price Today: Should You Buy or Not?
Anand Rathi Wealth Share Price Today: Should You Buy or Not?
NTPC Ltd Share Price Today: Should You Buy or Not?
Popular this week
Polycab India Share Price Today: Should You Buy or Not?
Sun Pharmaceutical Industries Share Price Today: Should You Buy or Not?
Sansera Engineering Share Price Today: Should You Buy or Not?
Anand Rathi Wealth Share Price Today: Should You Buy or Not?
NTPC Ltd Share Price Today: Should You Buy or Not?

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





